Cargando…
Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review
Background: There is a growing liberalization of cannabis-based preparations for medical and recreational use. In multiple instances, anxiety and depression are cited as either a primary or a secondary reason for the use of cannabinoids. Aim: The purpose of this review is to explore the association...
Autores principales: | Hasbi, Ahmed, Madras, Bertha K., George, Susan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953886/ https://www.ncbi.nlm.nih.gov/pubmed/36831868 http://dx.doi.org/10.3390/brainsci13020325 |
Ejemplares similares
-
Daily Δ(9)-Tetrahydrocannabinol and Withdrawal Increase Dopamine D(1)-D(2) Receptor Heteromer to Mediate Anhedonia- and Anxiogenic-like Behavior Through a Dynorphin and Kappa Opioid Receptor Mechanism
por: Hasbi, Ahmed, et al.
Publicado: (2022) -
Sex difference in dopamine D1-D2 receptor complex expression and signaling affects depression- and anxiety-like behaviors
por: Hasbi, Ahmed, et al.
Publicado: (2020) -
The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids
por: Kwan Cheung, Keith A., et al.
Publicado: (2019) -
The Endocannabinoid System, Cannabinoids, and Pain
por: Fine, Perry G., et al.
Publicado: (2013) -
Cannabinoids, Endocannabinoids and Sleep
por: Kesner, Andrew J., et al.
Publicado: (2020)